Top Key Companies for Alpha-Emitter Market: IBA Group, Mallinckrodt plc, Bayer AG, NTP Radioisotopes SOC Ltd, OrthAlign, Scopis, Zimmer, Lantheus Medical Imaging, Inc, General Electric Co, Zimmer Biomet Holdings, Inc., Z-Medical GmbH + Co. KG, Advanced Accelerator Applications S.A, Bracco Imaging S.p.A, Medtronic, plc, Cardinal Health, Inc..
Global Alpha-Emitter Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Alpha-Emitter Market Overview And Scope:
The Global Alpha-Emitter Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Alpha-Emitter utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Alpha-Emitter Market Segmentation
By Type, Alpha-Emitter market has been segmented into:
Terbium (Tb-149)
Astatine (At-211)
Bismuth (Bi-212)
Actinium (Ac-225)
Radium (Ra-223)
Lead (Pb-212)
Bismuth (Bi -213)
By Application, Alpha-Emitter market has been segmented into:
Glioma
Melanoma
Pancreatic Cancer
Ovarian Cancer
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Other Medical Applications
Regional Analysis of Alpha-Emitter Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Alpha-Emitter Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Alpha-Emitter market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Alpha-Emitter market.
Top Key Companies Covered in Alpha-Emitter market are:
IBA Group
Mallinckrodt plc
Bayer AG
NTP Radioisotopes SOC Ltd
OrthAlign
Scopis
Zimmer
Lantheus Medical Imaging
Inc
General Electric Co
Zimmer Biomet Holdings
Inc.
Z-Medical GmbH + Co. KG
Advanced Accelerator Applications S.A
Bracco Imaging S.p.A
Medtronic
plc
Cardinal Health
Inc.
Key Questions answered in the Alpha-Emitter Market Report:
1. What is the expected Alpha-Emitter Market size during the forecast period, 2026-2035?
2. Which region is the largest market for the Alpha-Emitter Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Alpha-Emitter Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Alpha-Emitter Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Alpha-Emitter companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Alpha-Emitter Markets?
7. How is the funding and investment landscape in the Alpha-Emitter Market?
8. Which are the leading consortiums and associations in the Alpha-Emitter Market, and what is their role in the market?
Research Methodology for Alpha-Emitter Market Report:
The report presents a detailed assessment of the Alpha-Emitter Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Alpha-Emitter Market by Type
5.1 Alpha-Emitter Market Overview Snapshot and Growth Engine
5.2 Alpha-Emitter Market Overview
5.3 Terbium (Tb-149)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Terbium (Tb-149): Geographic Segmentation
5.4 Astatine (At-211)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Astatine (At-211): Geographic Segmentation
5.5 Bismuth (Bi-212)
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Bismuth (Bi-212): Geographic Segmentation
5.6 Actinium (Ac-225)
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Actinium (Ac-225): Geographic Segmentation
5.7 Radium (Ra-223)
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Radium (Ra-223): Geographic Segmentation
5.8 Lead (Pb-212)
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2026-2035F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Lead (Pb-212): Geographic Segmentation
5.9 Bismuth (Bi -213)
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2026-2035F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Bismuth (Bi -213): Geographic Segmentation
Chapter 6: Alpha-Emitter Market by Application
6.1 Alpha-Emitter Market Overview Snapshot and Growth Engine
6.2 Alpha-Emitter Market Overview
6.3 Glioma
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Glioma: Geographic Segmentation
6.4 Melanoma
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Melanoma: Geographic Segmentation
6.5 Pancreatic Cancer
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Pancreatic Cancer: Geographic Segmentation
6.6 Ovarian Cancer
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Ovarian Cancer: Geographic Segmentation
6.7 Thyroid
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2026-2035F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Thyroid: Geographic Segmentation
6.8 Bone Metastasis
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2026-2035F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Bone Metastasis: Geographic Segmentation
6.9 Lymphoma
6.9.1 Introduction and Market Overview
6.9.2 Historic and Forecasted Market Size (2026-2035F)
6.9.3 Key Market Trends, Growth Factors and Opportunities
6.9.4 Lymphoma: Geographic Segmentation
6.10 Endocrine Tumors
6.10.1 Introduction and Market Overview
6.10.2 Historic and Forecasted Market Size (2026-2035F)
6.10.3 Key Market Trends, Growth Factors and Opportunities
6.10.4 Endocrine Tumors: Geographic Segmentation
6.11 Other Medical Applications
6.11.1 Introduction and Market Overview
6.11.2 Historic and Forecasted Market Size (2026-2035F)
6.11.3 Key Market Trends, Growth Factors and Opportunities
6.11.4 Other Medical Applications: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Alpha-Emitter Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Alpha-Emitter Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Alpha-Emitter Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 IBA GROUP
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MALLINCKRODT PLC
7.4 BAYER AG
7.5 NTP RADIOISOTOPES SOC LTD
7.6 ORTHALIGN
7.7 SCOPIS
7.8 ZIMMER
7.9 LANTHEUS MEDICAL IMAGING
7.10 INC
7.11 GENERAL ELECTRIC CO
7.12 ZIMMER BIOMET HOLDINGS
7.13 INC.
7.14 Z-MEDICAL GMBH + CO. KG
7.15 ADVANCED ACCELERATOR APPLICATIONS S.A
7.16 BRACCO IMAGING S.P.A
7.17 MEDTRONIC
7.18 PLC
7.19 CARDINAL HEALTH
7.20 INC.
Chapter 8: Global Alpha-Emitter Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Terbium (Tb-149)
8.2.2 Astatine (At-211)
8.2.3 Bismuth (Bi-212)
8.2.4 Actinium (Ac-225)
8.2.5 Radium (Ra-223)
8.2.6 Lead (Pb-212)
8.2.7 Bismuth (Bi -213)
8.3 Historic and Forecasted Market Size By Application
8.3.1 Glioma
8.3.2 Melanoma
8.3.3 Pancreatic Cancer
8.3.4 Ovarian Cancer
8.3.5 Thyroid
8.3.6 Bone Metastasis
8.3.7 Lymphoma
8.3.8 Endocrine Tumors
8.3.9 Other Medical Applications
Chapter 9: North America Alpha-Emitter Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Terbium (Tb-149)
9.4.2 Astatine (At-211)
9.4.3 Bismuth (Bi-212)
9.4.4 Actinium (Ac-225)
9.4.5 Radium (Ra-223)
9.4.6 Lead (Pb-212)
9.4.7 Bismuth (Bi -213)
9.5 Historic and Forecasted Market Size By Application
9.5.1 Glioma
9.5.2 Melanoma
9.5.3 Pancreatic Cancer
9.5.4 Ovarian Cancer
9.5.5 Thyroid
9.5.6 Bone Metastasis
9.5.7 Lymphoma
9.5.8 Endocrine Tumors
9.5.9 Other Medical Applications
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Alpha-Emitter Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Terbium (Tb-149)
10.4.2 Astatine (At-211)
10.4.3 Bismuth (Bi-212)
10.4.4 Actinium (Ac-225)
10.4.5 Radium (Ra-223)
10.4.6 Lead (Pb-212)
10.4.7 Bismuth (Bi -213)
10.5 Historic and Forecasted Market Size By Application
10.5.1 Glioma
10.5.2 Melanoma
10.5.3 Pancreatic Cancer
10.5.4 Ovarian Cancer
10.5.5 Thyroid
10.5.6 Bone Metastasis
10.5.7 Lymphoma
10.5.8 Endocrine Tumors
10.5.9 Other Medical Applications
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Alpha-Emitter Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Terbium (Tb-149)
11.4.2 Astatine (At-211)
11.4.3 Bismuth (Bi-212)
11.4.4 Actinium (Ac-225)
11.4.5 Radium (Ra-223)
11.4.6 Lead (Pb-212)
11.4.7 Bismuth (Bi -213)
11.5 Historic and Forecasted Market Size By Application
11.5.1 Glioma
11.5.2 Melanoma
11.5.3 Pancreatic Cancer
11.5.4 Ovarian Cancer
11.5.5 Thyroid
11.5.6 Bone Metastasis
11.5.7 Lymphoma
11.5.8 Endocrine Tumors
11.5.9 Other Medical Applications
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Alpha-Emitter Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Terbium (Tb-149)
12.4.2 Astatine (At-211)
12.4.3 Bismuth (Bi-212)
12.4.4 Actinium (Ac-225)
12.4.5 Radium (Ra-223)
12.4.6 Lead (Pb-212)
12.4.7 Bismuth (Bi -213)
12.5 Historic and Forecasted Market Size By Application
12.5.1 Glioma
12.5.2 Melanoma
12.5.3 Pancreatic Cancer
12.5.4 Ovarian Cancer
12.5.5 Thyroid
12.5.6 Bone Metastasis
12.5.7 Lymphoma
12.5.8 Endocrine Tumors
12.5.9 Other Medical Applications
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Alpha-Emitter Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Terbium (Tb-149)
13.4.2 Astatine (At-211)
13.4.3 Bismuth (Bi-212)
13.4.4 Actinium (Ac-225)
13.4.5 Radium (Ra-223)
13.4.6 Lead (Pb-212)
13.4.7 Bismuth (Bi -213)
13.5 Historic and Forecasted Market Size By Application
13.5.1 Glioma
13.5.2 Melanoma
13.5.3 Pancreatic Cancer
13.5.4 Ovarian Cancer
13.5.5 Thyroid
13.5.6 Bone Metastasis
13.5.7 Lymphoma
13.5.8 Endocrine Tumors
13.5.9 Other Medical Applications
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Alpha-Emitter Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Terbium (Tb-149)
14.4.2 Astatine (At-211)
14.4.3 Bismuth (Bi-212)
14.4.4 Actinium (Ac-225)
14.4.5 Radium (Ra-223)
14.4.6 Lead (Pb-212)
14.4.7 Bismuth (Bi -213)
14.5 Historic and Forecasted Market Size By Application
14.5.1 Glioma
14.5.2 Melanoma
14.5.3 Pancreatic Cancer
14.5.4 Ovarian Cancer
14.5.5 Thyroid
14.5.6 Bone Metastasis
14.5.7 Lymphoma
14.5.8 Endocrine Tumors
14.5.9 Other Medical Applications
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Alpha-Emitter Scope:
|
Report Data
|
Alpha-Emitter Market
|
|
Alpha-Emitter Market Size in 2025
|
USD XX million
|
|
Alpha-Emitter CAGR 2025 - 2032
|
XX%
|
|
Alpha-Emitter Base Year
|
2024
|
|
Alpha-Emitter Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
IBA Group, Mallinckrodt plc, Bayer AG, NTP Radioisotopes SOC Ltd, OrthAlign, Scopis, Zimmer, Lantheus Medical Imaging, Inc, General Electric Co, Zimmer Biomet Holdings, Inc., Z-Medical GmbH + Co. KG, Advanced Accelerator Applications S.A, Bracco Imaging S.p.A, Medtronic, plc, Cardinal Health, Inc..
|
|
Key Segments
|
By Type
Terbium (Tb-149) Astatine (At-211) Bismuth (Bi-212) Actinium (Ac-225) Radium (Ra-223) Lead (Pb-212) Bismuth (Bi -213)
By Applications
Glioma Melanoma Pancreatic Cancer Ovarian Cancer Thyroid Bone Metastasis Lymphoma Endocrine Tumors Other Medical Applications
|